pramipexole has been researched along with Nicotine Addiction in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aston, ER; Bloomfield, MAP; Curran, HV; Das, RK; East, K; Freeman, TP; Gaule, A; Lawn, W; Morgan, CJA | 1 |
Curran, HV; Das, RK; Freeman, TP; Kamboj, SK | 1 |
Domino, EF; Jutkiewicz, EM; Ohmura, Y; Zhang, A | 1 |
2 trial(s) available for pramipexole and Nicotine Addiction
Article | Year |
---|---|
The Acute Effects of a Dopamine D3 Receptor Preferring Agonist on Motivation for Cigarettes in Dependent and Occasional Cigarette Smokers.
Topics: Adult; Behavior, Addictive; Cigarette Smoking; Craving; Cross-Over Studies; Dopamine Agonists; Double-Blind Method; Female; Humans; Male; Motivation; Pramipexole; Receptors, Dopamine D3; Tobacco Use Disorder; Young Adult | 2018 |
Dopamine, urges to smoke, and the relative salience of drug versus non-drug reward.
Topics: Adolescent; Adult; Affect; Attention; Benzothiazoles; Craving; Cross-Over Studies; Cues; Dopamine; Dopamine Agonists; Double-Blind Method; Female; Humans; Male; Motivation; Photic Stimulation; Pramipexole; Reward; Smoking; Tobacco Use Disorder; Young Adult | 2015 |
1 other study(ies) available for pramipexole and Nicotine Addiction
Article | Year |
---|---|
Dopamine D1/5 and D2/3 agonists differentially attenuate somatic signs of nicotine withdrawal in rats.
Topics: Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Benzothiazoles; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Implants; Injections, Subcutaneous; Male; Nicotine; Nicotinic Agonists; Pramipexole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D5; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2011 |